PCIA
MRK icon

Prime Capital Investment Advisors’s Merck MRK Stock Holding History

Prime Capital Investment Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.6M Buy
46,549
+12,524
+37% +$1.45M 0.06% 207
2025
Q4 		$3.58M Sell
34,025
-20,072
-37% -$1.88M 0.04% 253
2025
Q3 		$4.54M Sell
54,097
-21,136
-28% -$1.74M 0.06% 211
2025
Q2 		$5.96M Sell
75,233
-151,576
-67% -$12M 0.08% 176
2025
Q1 		$20.4M Buy
226,809
+45,771
+25% +$4.27M 0.24% 80
2024
Q4 		$18M Sell
181,038
-2,859
-2% -$295K 0.26% 74
2024
Q3 		$20.9M Buy
183,897
+22,204
+14% +$2.64M 0.3% 67
2024
Q2 		$20M Sell
161,693
-37,864
-19% -$4.88M 0.3% 66
2024
Q1 		$26.3M Sell
199,557
-10,802
-5% -$1.33M 0.37% 63
2023
Q4 		$22.9M Buy
210,359
+38,115
+22% +$3.96M 0.35% 63
2023
Q3 		$17.7M Buy
172,244
+3,413
+2% +$368K 0.36% 64
2023
Q2 		$19.5M Buy
168,831
+85,705
+103% +$9.73M 0.38% 60
2023
Q1 		$8.84M Sell
83,126
-23,923
-22% -$2.58M 0.36% 63
2022
Q4 		$11.9M Buy
107,049
+35,741
+50% +$3.65M 0.45% 54
2022
Q3 		$6.14M Buy
71,308
+29,693
+71% +$2.65M 0.35% 55
2022
Q2 		$3.79M Buy
41,615
+14,545
+54% +$1.29M 0.23% 81
2022
Q1 		$2.08M Hold
27,070
– – 0.12% 128
2021
Q4 		$2.08M Buy
+27,070
New +$2.16M 0.11% 130
2021
Q3 		– Sell
-4,116
Closed -$320K – 356
2021
Q2 		$320K Buy
4,116
+603
+17% +$44.9K 0.02% 297
2021
Q1 		$258K Sell
3,513
-21,120
-86% -$1.56M 0.02% 233
2020
Q4 		$1.92M Buy
24,633
+1,374
+6% +$105K 0.15% 119
2020
Q3 		$1.84M Buy
23,259
+174
+0.8% +$13.6K 0.15% 116
2020
Q2 		$1.7M Buy
23,085
+21,692
+1,557% +$1.63M 0.16% 113
2020
Q1 		$102K Sell
1,393
-17,025
-92% -$1.34M 0.01% 234
2019
Q4 		$1.6M Buy
18,418
+332
+2% +$27.3K 0.18% 112
2019
Q3 		$1.45M Buy
18,086
+1,337
+8% +$107K 0.22% 107
2019
Q2 		$1.34M Buy
16,749
+16,713
+46,425% +$1.28M 0.24% 106
2019
Q1 		$3K Buy
+36
New +$2.69K ﹤0.01% 293
2018
Q4 		– Sell
-1,389
Closed -$94K – 409
2018
Q3 		$94K Buy
+1,389
New +$88.5K 0.03% 166

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prime Capital Investment Advisors's MRK Position: Q1 2026 in Review

Prime Capital Investment Advisors increased its Merck (MRK) stake by 37% in Q1 2026, buying an estimated $1.45M and bringing the position to 46,549 shares worth $5.6M. The position accounts for 0.06% of the portfolio, ranked #207.

Prime Capital Investment Advisors first reported a position in MRK in Q3 2018 and has held it in 29 quarters since. The position peaked at $26.3M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Prime Capital Investment Advisors held 46,549 shares of Merck worth $5.6M as of Q1 2026.
  • Prime Capital Investment Advisors bought 12,524 Merck shares in Q1 2026, an estimated $1.45M.
  • Merck made up 0.06% of Prime Capital Investment Advisors's portfolio in Q1 2026, its #207 holding.
  • Prime Capital Investment Advisors first reported a position in Merck in Q3 2018 and has held it in 29 quarters since.
  • Prime Capital Investment Advisors's Merck position peaked at $26.3M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.